Vivek Nama UHBT. Surgical staging: Tumour grade Myometrial invasion Lymphovascular space involvement Cervical stromal invasion Spread to regional lymphnodes.

Slides:

Advertisements

Similar presentations

CRITICAL APPRAISAL ON AN ARTICLE ABOUT PROGNOSIS

Advertisements

NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.

EUROCHIP PILOT STUDIES. Collection of detailed clinical information for specific tumours Describing and comparing care in representative samples of cancer.

March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.

Living with and beyond treatment for cancer – the challenge for secondary care Nigel Acheson Medical Director Peninsula Cancer Network.

Oesophageal Cancer. -improving outcomes. Anil Kaul Consultant General and Upper GI Surgery St Helens and Knowsley Teaching Hospitals NHS Trust.

62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.

Management of GIST Dr Kwan Ming Wa Tuen Mun Hospital.

Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)

A Survey of Quality of Life Following Surgery for Malignant Pleural Mesothelioma: Reflects the patients’ commitment to Learning about the Disease D A Raffle,

M Ravanbod Medical oncologist Bushehr – 11/91 A 50 y/o white man comes for check up and wants to discuss about prostate cancer. Negative family history.

Results of a Randomized Study of the JAK Inhibitor Ruxolitinib (INC424) versus Best Available Therapy (BAT) in Primary Myelofibrosis (PMF), Post- Polycythemia.

GCIG Meeting 29th May 2009 The Implications of Primary Chemotherapy for Clinical Trials Iain McNeish Professor of Gynaecological Oncology Barts and the.

AGO-OVAR DESKTOP III (Protocol AGO - OVAR OP.4)

Early treatment of relapsed ovarian cancer based on CA125 level alone

4% of all female cancers 25% of all gynecologic cancers life time risk: 1/70 ¾ advanced stage most lethal Epithelial Ovarian Cancer:

DAHANCA 16 Planned post-radiation neck dissection vs salvage neck dissection in patients with N2-3 SCC of the head and neck treated with primary radiotherapy.

Resection For Lung Metastases M62 Coloproctology Course.

Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,

Lymphadenectomy in Epithelial Ovarian Cancer

SPINDLE CELL SARCOMA OF BONE AN ASSESSMENT OF OUTCOME

Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.

SEER Provided Data Mohammad Afnan Baqai 12/3/2009.

EARLY PROGRESSION IN PATIENTS WITH HIGH-RISK SOFT TISSUE SARCOMAS AN ANALYSIS FROM A PHASE III RANDOMIZED PROSPECTIVE TRIAL (EORTC 62961/ESHO) OF NEOADJUVANT.

Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,

Health-related quality of life in patients with oesophageal- and gastric cancer Lovisa Backemar, MD Surgical Care Sciences Department of Molecular Medicine.

Quality of Life and Functional Results Following Pelvic Exenteration Erin Kennedy September 19, 2015.

Adjuvant treatment for endometrial cancer Ameri A Associate Professor of Radiation Oncology Shahid Beheshti University of Medical Sciences Dec Pars.

HERA TRIAL: 2 Years versus 1 Year of Trastuzumab After Adjuvant Chemotherapy in Women with HER2-Positive Early Breast Cancer at 8 Years of Median Follow-Up.

UK Clinical Sarcoma Research. Changes in UK Appointment of Cancer Tsar Use of NICE to evaluate care pathways and technology/drugs Minimum datasets established.

Janet H. Van Cleave PhD, RN1 Brian Egleston PhD2

Hysterectomy after Chemoradiotherapy for Stage Ib2 and IIb Cervical Cancer Vivek Nama UHBT.

NHMRC Clinical Trials Centre ANZGOG AGM, 2 April 2009, Noosa NHMRC Clinical Trials Centre Symptom Benefit Study Measuring the Benefit of Palliative Chemotherapy.

Early Treatment of Relapsed Ovarian Cancer Based on CA125 Level Alone Versus Delayed Treatment Based on Conventional Clinical Indicators Results of the.

CoRPS Center of Research on Psychology in Somatic diseases Multiple myeloma survivors experience a low quality of life and many disease-specific complaints:

Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.

Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.

Drinking to cope, alcohol and cigarette use, and quality of life in successfully treated HNSCC patients A.K.H. Aarstad  H.J. Aarstad J. Olofsson Department.

HE-4 TRIAL Prospective phase II trial on the prognostic and predictive value of HE-4 regression during neoadjuvant chemotherapy for advanced ovarian, Fallopian.

D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer NEJM July vol 359 R2 임규성.

What’s New in Endometrial Cancer Henry Kitchener April 2009.

1 LUX-Lung 3 clinical trial ECOG=Eastern Cooperative Oncology Group. Sequist LV et al. J Clin Oncol. 2013;31(27): Treatment-naïve Advanced NSCLC.

ELIGIBILITY CRITERIA- Summarised

Liver surgery for metachronous hepatic metastases with uterine body and uterine cervix origin – a single center experience Nicolae Bacalbasa (1), Irina.

LUX-Lung 6 clinical trial

LUX-Lung 3 clinical trial

Bronchial Carcinoma Part 2

Overzicht activiteiten werkgroep medicamenteuze therapie

عنوان مقاله: Primary Gastric Lymphoma: Clinicopathologic study of

Long Term Effects of Surgery and Radiotherapy for Colorectal Cancer on Bowel Function and Quality of Life Gillian Knowles, Rachel Haigh, Catriona McLean,

Your Symptoms Matter – Prostate Cancer

Prognosis of younger patients in non-small cell lung cancer

Bones Cancer The primary bone cancer is a rare type of cancer that affects the human skeleton. Unlike the secondary, originates in the bone and not the.

Results: Patient details Results: QoL

Laparoscopic vs Open Colonic Surgery: Long Term Survival

Table 1 Baseline patient characteristics

Intervista a Lucio Crinò

Stereotactic ablative radiotherapy (SABR) versus lobectomy for operable stage I NSCLC Julia Myers.

Pericervical injection of 99mTc-Nanocolloid IS superior to peritumoral injection for sentinel lymph node detection in SPECT/CT Dr. Martin Weiss Department.

Apollo Gleneagles Hospitals,

Charles D. Gerson, Mary-Joan Gerson

What is New in Hormone Therapy for Prostate Cancer in 2007?

Sarcoma Wound Complications

Investigator - Dr Pramod S. Chinder

ACT II: The Second UK Phase III Anal Cancer Trial

Clinical Fellow Gynaeoncology Musgrove Park Hospital, Taunton

Management of endometrial cancer found on routine hysterectomy for benign disease Prof Dr M Anıl Onan MAY ANTALYA.

Mean difference between treatment groups in the change from baseline for all PRO scores at months 1, 2 and 3. *Evaluable patients. Mean difference between.

Volume 373, Issue 9658, Pages (January 2009)

Presentation transcript:

Vivek Nama UHBT

Surgical staging: Tumour grade Myometrial invasion Lymphovascular space involvement Cervical stromal invasion Spread to regional lymphnodes Decreased survival

Evidence at its best- ASTEC trial Factorial design 700 patients Panici Trial 300 patients Recurrence rates are low – sample size

Balance Surgery Radiother apy

What outcomes? Survival Quality of life Cost

Total Cases 335 Cases included 278 FIGO Stage 1A 184 FIGO Stage 1B 52 FIGO Stage 2 42 Sarcomas 12 No Surgery 17 FIGO Stage > 2 28

Lymphnode Involvement:

ProcedurePer Unit CostAll Grades (n=278)Grade 2 &3 (n=162) EBRT+VBT£7,823.74£ 618, (n=79) Lymphadenectomy£1,000.00£ 278,000 (n=278)£ 162,000 (n=162) Lymphnode positive (EBRT) (Lymphnode positivity as 5.35%, SEER data) £ 74,592 (n=14.38) £ 46,177.7 (n=8.6)+£ 46, (n=6 from G1) = £ VBT only£2,495.76£ 187,182 (n=75)£ 184, (n=74) Cost Savings£ 78,301£ 178, Cost Savings/100 patients £ 28,057£ 110,042.59

EBRT prevented: All Grades – % 75 of the 79 (94.43%) Grade 2 and 3 cancers 40.74% of all patients needing EBRT 66 cases of the total 71 (92.95%)

Quality of Life? Quality of Life and Symptoms ScalesSig.* 1The medians of Age are the same across categories of treatment The medians of Urinary score are the same across categories of treatment The medians of Global Health score are the same across categories of treatment The medians of Physical functioning score are the same across categories of treatment The medians of Bowel score are the same across categories of treatment The medians of Fatigue final score are the same across categories of treatment The medians of Nausea and vomiting score are the same across categories of treatment The medians of Pain score are the same across categories of treatment..020

Trial Primary Outcome: Quality of life Cost Secondary Outcome: Disease free survival Overall Survival

Service Evaluation Pre Treatment Standard Treatment Follow up QLQC – 30/EN 24

How to Collect Paper Based Web Based Iphone/Ipad based

Analysis: Quality of life based on EORTC manual Overall Survival Disease Free Survival Cost

Next Steps: PPI – Moving on day Surgical Trials unit Funding for administrator Web based platform